Ibritumomab tiuxetan

From WikiMD
Jump to navigation Jump to search

ibritumomab tiuxetan

 (ih-brih-TOO-moh-mab ty-UK-seh-tan)A drug used to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Ibritumomab tiuxetan contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells and some types of lymphoma cells. It also contains the compound tiuxetan, which allows certain radioactive substances to be attached to the monoclonal antibody. This may help kill cancer cells. Ibritumomab tiuxetan is a type of monoclonal antibody and a type of immunoconjugate. Also called Zevalin.

W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP*

Quick links: Medicine Portal | Encyclopedia‏‎‏‎ | Gray's Anatomy‏‎ | Topics‏‎ |‏‎ Diseases‏‎ | Drugs | Wellness | Obesity‏‎ | Metabolic syndrome | Weight loss*
Disclaimer: The entire contents of WIKIMD.ORG are for informational purposes only and do not render medical advice or professional services. If you have a medical emergency, you should CALL 911 immediately! Given the nature of the wiki, the information provided may not be accurate, misleading and or incorrect. Use the information on this wiki at your own risk! See full Disclaimer.
Link to this page: <a href="http://www.wikimd.org/wiki/Ibritumomab_tiuxetan">Ibritumomab tiuxetan</a>

  • Individual results may vary for weight loss from our sponsors.